Ruckwardt, T. J., Morabito, K. M., Phung, E., Crank, M. C., Costner, P. J., Holman, L. A., Chang, L. A., Hickman, S. P., Berkowitz, N. M., Gordon, I. J., Yamshchikov, G. V., Gaudinski, M. R., Lin, B., Bailer, R., Chen, M., Ortega-Villa, A. M., Nguyen, T., Kumar, A., Schwartz, R. M., Kueltzo, L. A., Stein, J. A., Carlton, K., Gall, J. G., Nason, M. C., Mascola, J. R., Chen, G., Graham, B. S., , , Arthur, A., Cunningham, J., Eshun, A., Larkin, B., Mendoza, F., Novik, L., Saunders, J., Wang, X., Whalen, W., Carter, C., Hendel, C. S., Plummer, S., Ola, A., Widge, A., Burgos Florez, M. C., Le, L., Pittman, I., Rothwell, R. S. S., Trofymenko, O., Vasilenko, O., Apte, P., Hicks, R., Cartagena, C. T., Williams, P., Requilman, L., Tran, C., Bai, S., Carey, E., Chamberlain, A. L., Chang, Y., Chen, M., Chen, P., Cooper, J., Fridley, C., Ghosh, M., Gollapudi, D., Holland-Linn, J., Horwitz, J., Hussain, A., Ivleva, V., Kaltovich, F., Leach, K., Lee, C., Liu, A., Liu, X., Manceva, S., Menon, A., Nagy, A., O'Connell, S., Ragunathan, R., Walters, J., & Zhao, Z. (2021). safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial. Lancet, 9(10), 1111–1120. http://access.bl.uk/ark:/81055/vdc_100144251823.0x00000d